These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21890248)

  • 1. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; El-Hazek RM
    Eur J Med Chem; 2011 Oct; 46(10):5120-6. PubMed ID: 21890248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety.
    Ghorab MM; Shaaban MA; Refaat HM; Heiba HI; Ibrahim SS
    Eur J Med Chem; 2012 Jul; 53():403-7. PubMed ID: 22583778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
    Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
    Ghorab MM; Ragab FA; Hamed MM
    Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of γ-radiation.
    Ghorab MM; Ragab FA; Heiba HI; Nissan YM; Ghorab WM
    Arch Pharm Res; 2012 Aug; 35(8):1335-46. PubMed ID: 22941476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and docking studies of some novel quinoline derivatives bearing a sulfonamide moiety as possible anticancer agents.
    Ghorab MM; Ragab FA; Hamed MM
    Arzneimittelforschung; 2010; 60(3):141-8. PubMed ID: 20422946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.
    Al-Said MS; Ghorab MM; Al-Dosari MS; Hamed MM
    Eur J Med Chem; 2011 Jan; 46(1):201-7. PubMed ID: 21112675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
    Al-Said MS; Ghorab MM; Al-Qasoumi SI; El-Hossary EM; Noaman E
    Eur J Med Chem; 2010 Jul; 45(7):3011-8. PubMed ID: 20413187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of some new pyrazole and pyrimidine derivatives carrying a sulfonamide moiety of expected antitumor activity and study of the synergistic effect of gamma-irradiation.
    Ghorab MM; Ragab FA; Heiba HI; Youssef HA; Galal M
    Arzneimittelforschung; 2010; 60(1):48-55. PubMed ID: 20184227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of methyl 2-isothiocyanatobenzoate in the synthesis of some new quinazoline derivatives as potential anticancer and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Bayomi AA
    Arzneimittelforschung; 2011; 61(12):719-26. PubMed ID: 22282960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
    Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives.
    Al-Said MS; Bashandy MS; Al-Qasoumi SI; Ghorab MM
    Eur J Med Chem; 2011 Jan; 46(1):137-41. PubMed ID: 21093116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues.
    Al-Omary FA; Hassan GS; El-Messery SM; El-Subbagh HI
    Eur J Med Chem; 2012 Jan; 47(1):65-72. PubMed ID: 22056277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.
    Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel thiophenes, thienopyrimidines, and triazolothienopyrimidines for the evaluation of anticancer and augmentation effects of gamma-radiation.
    Shaaban MA; Ghorab MM; Heiba HI; Kamel MM; Zaher NH; Mostafa MI
    Arch Pharm (Weinheim); 2010 Jul; 343(7):404-10. PubMed ID: 20379969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pyrazole derivatives as anticancer and radiosensitizing agents.
    Aly HM; El-Gazzar MG
    Arzneimittelforschung; 2012 Mar; 62(3):105-12. PubMed ID: 22407898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
    Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W
    Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activities of some newly synthesized pyridine, pyrane, and pyrimidine derivatives.
    Amr AG; Mohamed AM; Mohamed SF; Abdel-Hafez NA; Hammam Ael-F
    Bioorg Med Chem; 2006 Aug; 14(16):5481-8. PubMed ID: 16713269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 4-(4-substituted-thiazol-2-ylamino)-N-(pyridin-2-yl)-benzenesulfonamides as cytotoxic and radiosensitizing agents.
    Ghorab MM; Ragab FA; Heiba HI; Agha HM; Nissan YM
    Arch Pharm Res; 2012 Jan; 35(1):59-68. PubMed ID: 22297743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.